Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06909058 · ClinicalTrials.gov registry record · NA

Postoperative Restrictions for Patients Undergoing Minimally Invasive Gynecologic Procedures

A NA study of Postoperative Care and MIGS, sponsored by Anna Frappaolo.

Active
Registry status
NA
Development phase
148
Enrollment target
1
Study location

NCT06909058: Active NA study of Postoperative Care and MIGS, sponsored by Anna Frappaolo.

NCT06909058 is a NA study of Postoperative Care and MIGS that is active but no longer recruiting, run by Anna Frappaolo. The registered enrollment target is 148 participants, above the 110-participant average among 4 other Postoperative Care trials with a reported enrollment target (35% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06909058, a NA study of Postoperative Care and MIGS, is active but no longer recruiting, sponsored by Anna Frappaolo.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
148 participants
Enrollment target
1
Study location

Study Summary

The goal of this randomized controlled trial is to assess recovery in patients undergoing benign laparoscopic gynecologic surgery. The main question it aims to answer is: do liberalized postoperative restrictions improve patient recovery after laparoscopic gynecologic surgery? Researchers will compare postoperative recovery surveys from the control group (patients given standard postoperative restrictions limiting activity for 2 weeks) to the research group (patients given liberalized postoperative instructions allowing them to engage in their normal activities of daily life at their own discretion without prescribed activity restrictions) to see if liberalized postoperative restrictions improve the recovery experience. Participants will be asked to fill out a brief questionnaire at two time intervals, 1 week after surgery and 2 weeks after surgery.

Primary Outcome

Postoperative recovery will be evaluated using the Recovery Index-10 (RI-10), a recovery-specific instrument to assess subjective postoperative recovery that is specifically validated for gynecologic surgery. It is graded on a 5-point numerical Likert scale ranging from "full disagreement" to "full agreement." The questionnaire asks questions regarding pain, stamina/ability to complete daily chores, energy, and sleep. Prior literature on the use and validation of RI-10 suggests a standard deviat

Conditions Studied

Interventions

  • BEHAVIORAL Study Postoperative Care

Study Locations (1)

Rhode Island

  • Women and Infants Hospital - Providence

Trial Details

FieldValue
Enrollment Target 148 participants
Start Date 2025-04-07
Est. Completion 2026-02-01
Phase NA
Anna Frappaolo

1 total trials

What the registry record for NCT06909058 still lists

NCT06909058 is an interventional study that assigns participants to a tested intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, above the 110-participant average among 4 other Postoperative Care trials with a reported enrollment target (35% higher).

The record links to 2 conditions, with Postoperative Care appearing as the primary indexed condition, and to 1 intervention - of which Study Postoperative Care is the first listed.

NCT06909058 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT06909058 about?

NCT06909058 is a clinical study titled "Postoperative Restrictions for Patients Undergoing Minimally Invasive Gynecologic Procedures". The goal of this randomized controlled trial is to assess recovery in patients undergoing benign laparoscopic gynecologic surgery. The main question it aims to answer is: do liberalized postoperative restrictions improve patient recovery after laparoscopic gynecologic surgery? Researchers will comp...

What is the current status of trial NCT06909058?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 148 participants. The study started on 2025-04-07. Estimated completion is 2026-02-01.

What conditions does trial NCT06909058 study?

This clinical trial studies the following conditions: Postoperative Care, MIGS.

What interventions are being tested in trial NCT06909058?

The interventions under investigation include: Study Postoperative Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT06909058?

This trial is sponsored by Anna Frappaolo, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06909058 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postoperative Care

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00739362 · 148 participants · Phase 2

    Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment

  • NCT03161223 · 148 participants · Phase 1

    Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma

  • NCT03858231 · 148 participants · Phase 4

    Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery

  • NCT04486352 · 148 participants · Phase 1

    A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06909058, the US trial registry maintained by the National Library of Medicine. NCT06909058 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.